Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance

S Mirzaei, AT Mohammadi, MH Gholami… - Pharmacological …, 2021 - Elsevier
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a vital transcription factor and its induction
is of significant importance for protecting against oxidative damage. Increased levels of …

Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implications

T Liu, YF Lv, JL Zhao, QD You, ZY Jiang - Free Radical Biology and …, 2021 - Elsevier
The transcription factor nuclear factor erythroid-derived 2-like 2 (NRF2) participates in the
activation of the antioxidant cytoprotective pathway and other important physiological …

Role of NRF2 in lung cancer

M Sánchez-Ortega, AC Carrera, A Garrido - Cells, 2021 - mdpi.com
The gene expression program induced by NRF2 transcription factor plays a critical role in
cell defense responses against a broad variety of cellular stresses, most importantly …

Role of Nrf2 signaling cascade in breast cancer: strategies and treatment

H Kumar, RM Kumar, D Bhattacharjee… - Frontiers in …, 2022 - frontiersin.org
Breast cancer is the second leading cancer among all types of cancers. It accounts for 12%
of the total cases of cancers. The complex and heterogeneous nature of breast cancer …

Epigenetic regulation of NRF2/KEAP1 by phytochemicals

S Bhattacharjee, RH Dashwood - Antioxidants, 2020 - mdpi.com
Epigenetics has provided a new dimension to our understanding of nuclear factor erythroid
2–related factor 2/Kelch-like ECH-associated protein 1 (human NRF2/KEAP1 and murine …

The role of AKR1B10 in physiology and pathophysiology

S Endo, T Matsunaga, T Nishinaka - Metabolites, 2021 - mdpi.com
AKR1B10 is a human nicotinamide adenine dinucleotide phosphate (NADPH)-dependent
reductase belonging to the aldo-keto reductase (AKR) 1B subfamily. It catalyzes the …

MYH9 facilitates cell invasion and radioresistance in head and neck cancer via modulation of cellular ROS levels by activating the MAPK-Nrf2-GCLC pathway

GR You, JT Chang, YL Li, CW Huang, YL Tsai, KH Fan… - Cells, 2022 - mdpi.com
The MYH9 (Myosin heavy chain 9), an architecture component of the actomyosin
cytoskeleton, has been reported to be dysregulated in several types of cancers. However …

The NRF2 antagonist ML385 inhibits PI3K‐mTOR signaling and growth of lung squamous cell carcinoma cells

L Ji, N Moghal, X Zou, Y Fang, S Hu, Y Wang… - Cancer …, 2023 - Wiley Online Library
Background Lung squamous cell carcinoma (LUSC) currently has limited therapeutic
options because of the relatively few validated targets and the lack of clinical drugs for some …

The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario

AG Mukherjee, AV Gopalakrishnan - Medical Oncology, 2023 - Springer
The Nuclear factor erythroid 2-related factor 2 (Nrf2) protein has garnered significant interest
due to its crucial function in safeguarding cells and tissues. The Nrf2 protein is crucial in …

Identification of key proteins in the signaling crossroads between wound healing and cancer hallmark phenotypes

A López-Cortés, E Abarca, L Silva, E Velastegui… - Scientific Reports, 2021 - nature.com
Wound healing (WH) and cancer seem to share common cellular and molecular processes
that could work in a tight balance to maintain tissue homeostasis or, when unregulated, drive …